Skip to main content

Advertisement

Peer Review reports

From: Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim

Original Submission
27 Jan 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
19 Mar 2014 Reviewed Reviewer Report - ARM AMIN
20 Mar 2014 Reviewed Reviewer Report - Xiangguo Liu
12 May 2014 Author responded Author comments - Byoung Heon Kang
Resubmission - Version 3
12 May 2014 Submitted Manuscript version 3
15 May 2014 Reviewed Reviewer Report - Xiangguo Liu
20 May 2014 Reviewed Reviewer Report - ARM AMIN
28 May 2014 Author responded Author comments - Byoung Heon Kang
Resubmission - Version 4
28 May 2014 Submitted Manuscript version 4
5 Jun 2014 Author responded Author comments - Byoung Heon Kang
Resubmission - Version 5
5 Jun 2014 Submitted Manuscript version 5
9 Jun 2014 Author responded Author comments - Byoung Heon Kang
Resubmission - Version 6
9 Jun 2014 Submitted Manuscript version 6
Publishing
9 Jun 2014 Editorially accepted
13 Jun 2014 Article published 10.1186/1471-2407-14-431

You can find further information about peer review here.

Back to article page